Surgery

Biography

Biography: Dida Kazakova

Abstract

For more than 30 years patients with glaucoma have been treated with laser trabeculoplasty. While looking for  an effective and save alternative to argon laser trabecoloplasty. Mark Latina et al. develop the selective laser trabeculoplasty. For nearly 12 years of usage, it not only replaces argon laser trabeculoplasty, but also establishes as a trustful method for IOP lowering with extremely low post-operative complications. The results of many researchers prove that selective laser trabeculoplasty is successful in wide range of open angle glaucoma patients. Recent data shows that under some conditions, patients with angle closure glaucoma and steroid induced glaucoma can also be treated. One of the most discussed issues about the selective laser trabeculoplasty remains the duration of the IOP -lowering effect of the procedure. The procedure shows a very good IOP lowering effect as a first line therapy as well as when it is used as an adjunctive therapy to a drug treatment. The aim of presentation is to summarize the information in the open literature about mechanisms of action, indications, procedure modifications and effectiveness of the selective laser trabeculoplasty.